Table 2.
IC50 of NB cell lines treated with GX 15–070 and cisplatin
| NB cell lines | IC50 (μM) | IC50 (μM) | IC50 (μM) |
|---|---|---|---|
| Cisa | Cisa + 0,05 μM GX 15–070 | Cisa + 0,5 μM GX 15–070 | |
| SK-N-DZ | 0,409 | 0,078 | 0,055 |
| IGR-NB8 | 13,01 | 4439 | 0,043 |
aCis cisplatin
IC50 of NB cell lines treated with GX 15–070 and cisplatin
| NB cell lines | IC50 (μM) | IC50 (μM) | IC50 (μM) |
|---|---|---|---|
| Cisa | Cisa + 0,05 μM GX 15–070 | Cisa + 0,5 μM GX 15–070 | |
| SK-N-DZ | 0,409 | 0,078 | 0,055 |
| IGR-NB8 | 13,01 | 4439 | 0,043 |
aCis cisplatin